These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38835013)

  • 1. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
    Chen Y; Dai X; Wu B; Jiang C; Yin Y
    BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
    Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
    J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes.
    Brajenović-Milić B; Tislarić D; Zuvić-Butorac M; Bacić J; Petrović O; Ristić S; Mimica M; Kapović M
    Fetal Diagn Ther; 2004; 19(6):483-7. PubMed ID: 15539871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
    Hu Z; Liu X; Li L; Jia C; Li D; Liu R
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal growth retardation and second trimester maternal serum human chorionic gonadotrophin levels.
    Luckas MJ; Sandland R; Hawe J; Neilson JP; McFadyen IR; Meekins JW
    Placenta; 1998; 19(2-3):143-7. PubMed ID: 9548180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes.
    Sirikunalai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
    J Obstet Gynaecol; 2016; 36(2):178-82. PubMed ID: 26368010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study.
    Dai X; Zhang H; Wu B; Ning W; Chen Y; Chen Y
    Clin Exp Hypertens; 2023 Dec; 45(1):2175848. PubMed ID: 36849437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
    Lepage N; Chitayat D; Kingdom J; Huang T
    Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal first trimester serum levels of free-beta human chorionic gonadotrophin and male genital anomalies.
    Schneuer FJ; Bower C; Holland AJ; Tasevski V; Jamieson SE; Barker A; Lee L; Majzoub JA; Nassar N
    Hum Reprod; 2016 Aug; 31(8):1895-903. PubMed ID: 27496947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
    Gravett CP; Buckmaster JG; Watson PT; Gravett MG
    Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between maternal serum first trimester free βhCG, second trimester intact hCG levels and foetal growth restriction and preeclampsia.
    Sharony R; Sharon-Weiner M; Kidron D; Sukenik-Halevy R; Biron-Shental T; Manor M; Reinstein E; Maymon R
    J Obstet Gynaecol; 2018 Apr; 38(3):363-366. PubMed ID: 29385871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion.
    Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
    Am J Perinatol; 1996 Oct; 13(7):437-41. PubMed ID: 8960614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
    Toal M; Chaddha V; Windrim R; Kingdom J
    J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
    Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
    Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
    Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
    Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.